Mon HC, Huang YH. Reply to "Immune checkpoint inhibitor therapy for functional cure of hepatitis B in cancer patients: a promising strategy?" and "Hepatocellular Carcinoma Patients as an Ideal Study Population for Immune Checkpoint Inhibitors in Hepatitis B". J Hepatol 2024 Nov 8:S0168-8278(24)02701-6. doi: 10.1016/j.jhep.2024.
PMID: 39522885